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STAT-3 Activation Is Required
for Normal G-CSF-Dependent Proliferation
and Granulocytic Differentiation
hematopoietic cells lines with G-CSF resulted in their
granulocytic differentiation (Dong et al., 1993; Fukunaga
et al., 1993; Ziegler et al., 1993). These studies led to the
hypothesis that G-CSFR signals were actively directing
terminal granulocytic differentiation. However, in mice
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lacking G-CSF or the G-CSFR, morphologically matureWashington University School of Medicine
neutrophils are produced (albeit at reduced levels),St. Louis, Missouri 63110
showing that G-CSFR signals are not required for granu-
locytic differentiation (Lieschke et al., 1994; Liu et al.,
1996). Although not required, these observations do notSummary
exclude a significant role for G-CSFR signals in the regu-
lation of granulocytic differentiation. Indeed, recentTo investigate the role of signal transducer and activa-
studies suggest that G-CSFR signals may regulate ex-tor of transcription (STAT) proteins in granulocyte col-
pression of PU.1 and CCAAT enhancer binding proteinony-stimulating factor (G-CSF)-regulated biological
e (C-EBPe), two key transcription factors controllingresponses, we generated transgenic mice with a tar-
granulocytic differentiation (H. Nakajima et al., 1998,geted mutation of their G-CSF receptor (termed d715F)
Blood, abstract; Lutz et al., 2000). These latter observa-that abolishes G-CSF-dependent STAT-3 activation
tions may provide a potential mechanism for the long-and attenuates STAT-5 activation. Homozygous mu-
standing observation that G-CSF treatment reduces thetant mice are severely neutropenic with an accumula-
“transit time” for myeloid precursors to differentiate totion of immature myeloid precursors in their bone mar-
mature neutrophils (Lord et al., 1989).row. G-CSF-induced proliferation and granulocytic
To investigate the specificity of cytokine receptor sig-differentiation of hematopoietic progenitors is se-
nals in the regulation of hematopoietic differentiation,verely impaired. Expression of a constitutively active
we recently generated mice carrying a targeted mutationform of STAT-3 in d715F progenitors nearly completely
of their G-CSFR such that the cytoplasmic (signaling)rescued these defects. Conversely, expression of a
domain of the G-CSFR is replaced with that of the eryth-dominant-negative form of STAT-3 in wild-type pro-
ropoietin receptor (Semerad et al., 1999). These micegenitors results in impaired G-CSF-induced prolifera-
are predicted to express, in a myeloid-specific fashion,tion and differentiation. These data suggest that STAT-3
a chimeric receptor (G:EpoR) that is activated by G-CSFactivation by the G-CSFR is critical for the transduc-
but transduces eryhtropoietin-specific signals. We showedtion of normal proliferative signals and contributes to
that morphologically mature neutrophils were still pro-differentiative signals.
duced in these mice and that G:EpoR signals could
support terminal granulocytic differentiation in vitro.Introduction
However, mutant neutrophils displayed defective che-
motaxis, and their trafficking from the bone marrow toGranulocyte colony-stimulating factor (G-CSF) is the
blood was impaired. Collectively, these data suggestedprincipal hematopoietic growth factor regulating the
that the G-CSFR is generating unique signals that areproduction of neutrophils, and it is widely used to treat
required for certain specialized hematopoietic cell func-neutropenia in a variety of clinical settings (Welte et al.,
tions but are not required for granulocytic differentiation.1996). The effects of G-CSF are solely mediated through
Signal transducer and activator of transcription (STAT)
its interaction with the granulocyte colony-stimulating
proteins are latent cytoplasmic transcription factors that
factor receptor (G-CSFR), a member of the hematopoi-
are activated by a broad range of hematopoietic cyto-
etic cytokine receptor superfamily. G-CSF has three kine receptors (Chakraborty and Tweardy, 1998; Ward
major biologic actions. It increases the production and et al., 2000). Recent data suggest that STAT proteins
release of neutrophils from the marrow, mobilizes hema- may play an important role in the regulation of hemato-
topoietic progenitor cells from the marrow to the blood, poietic cell proliferation, differentiation, and function
and modulates certain effector functions of mature neu- (Smithgall et al., 2000; Ward et al., 2000). Moreover,
trophils (de Haas et al., 1994; Bober et al., 1995; Welte perturbations in the regulation of their activation may
et al., 1996; Carulli, 1997; Hoglund et al., 1997). The contribute to the pathogenesis of certain hematopoietic
importance of G-CSF to the regulation of basal granulo- disorders, including myeloproliferative and lymphopro-
poiesis has been confirmed by the observation of severe liferative disorders (Gouilleux-Gruart et al., 1997; Catlett-
neutropenia in mice carrying homozygous deletions of Falcone et al., 1999; Ward et al., 2000). STAT-3 is the
their G-CSF or G-CSFR genes (Lieschke et al., 1994; Liu principal STAT protein activated by the G-CSFR, with
et al., 1996). STAT-5 and STAT-1 also activated to a lesser degree
The contribution of G-CSFR signals to the regulation (Tian et al., 1994; Avalos, 1996; Chakraborty et al., 1996;
of granulocytic differentiation is controversial. Early Ward et al., 1999). The contribution of STAT-3 to the
studies showed that treatment of certain immortalized signal transduction of the G-CSFR’s diverse biological
activities is largely unknown. Expression of dominant-
negative forms of STAT-3 in certain myeloid cell lines* To whom correpondence should be addressed (e-mail: dlink@im.
wustl.edu). leads to sustained G-CSF proliferation without granulo-
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cytic differentiation, indicating that STAT-3 activation is a quantitative flow cytometric method to detect specific
binding of biotinylated G-CSF. Specific G-CSF bindingrequired for G-CSF-dependent granulocytic differentia-
tion (Shimozaki et al., 1997; de Koning et al., 2000). In was detected on d715F neutrophils (Figure 1C) but not
lymphocytes (data not shown), indicating myeloid-spe-contrast, in transgenic mice in which the STAT-3 gene
was deleted in a myeloid-specific fashion, the produc- cific expression. Relative to wild-type neutrophils, a
modest increase in G-CSF binding was observed withtion of morphologically mature neutrophils was appar-
ently normal, although significant functional defects d715F and, as previously described, with d715 neutro-
phils. Since the observed increase in G-CSF bindingwere detected in mature neutrophils (Takeda et al.,
1999). could represent an increase in receptor number or re-
ceptor affinity for ligand, ligand binding studies on wild-To further characterize the contribution of STAT-3 to
the regulation of granulopoiesis, we generated a tar- type or d715F bone marrow cells were performed using
radiolabeled G-CSF. The calculated dissociation con-geted mutation in mice that results in the production of
a mutant G-CSFR (termed d715F) in which the distal 98 stants (Kd) for wild-type and d715F cells were similar
(137 and 155 pM, respectively) and are consistent withamino acids are deleted and the sole remaining cyto-
plasmic tyrosine (Y704) is mutated to phenylalanine. Im- previously published data for wild-type murine G-CSFR
(Nicola and Metcalf, 1985; Watanabe et al., 1991). Col-portantly, we previously showed that mice expressing
an identically truncated G-CSFR but with Y704 intact lectively, these data suggest that the number of G-CSFR
receptors is modestly increased on d715F neutrophils(termed d715) had normal granulopoiesis and activated
STAT-3 in response to G-CSF (McLemore et al., 1998). but their binding affinity for G-CSF is normal.
Herein, we demonstrate that activation of STAT-3 by
the d715F G-CSFR is absent in primary hematopoietic STAT-3 and STAT-5 Activation by the d715F
cells and STAT-5 activation markedly attenuated. G-CSF- G-CSFR Are Markedly Impaired
induced cellular proliferation and differentiation by the Previous studies have shown that stimulation of the
d715F G-CSFR is impaired leading to defective granulo- d715 G-CSFR results in near normal STAT-3 activation
poiesis in vivo. These defects could be partially rescued and sustained activation of STAT-5 (Hermans et al.,
by expression of a constitutively active form of STAT3, 1998, 1999). To assess the ability of the d715F G-CSFR
suggesting that activation of STAT-3 is critical for G-CSF- to activate STAT proteins, bone marrow cells were har-
induced cellular proliferation and possibly granulocytic vested from mice of each genotype, stimulated with
differentiation. Conversely, expression of a dominant- G-CSF (or control cytokines), and the activation of STAT
negative form of STAT-3 in wild-type progenitors results proteins assessed using an electrophoretic mobility shift
in impaired G-CSF-induced proliferation and differentia- assay (Figure 2A). As expected, STAT-3 activation was
tion, providing further support for the hypothesis that readily observed 10 min after G-CSF stimulation of wild-
STAT-3 activation plays a critical role in G-CSF-depen- type and d715 bone marrow cells. In contrast, no STAT-3
dent proliferation and granulocytic differentiation. activation was detected in d715F bone marrow cells
anytime from 5–120 min after G-CSF stimulation (Figure
2A; data not shown). Surprisingly, STAT-5 activation byResults
the d715F G-CSFR also was markedly impaired. Al-
though a low level of STAT-5 activation could be de-Generation of G-CSFR Mutant Mice
tected after prolonged exposure to G-CSF (at least 30Mice carrying two different targeted G-CSFR muta-
min), no STAT-5 activation was detected 10 min aftertions were examined in this study (Figure 1A). The gener-
stimulation with G-CSF (Figure 2B; data not shown).ation and characterization of mice homozygous for the
STAT-1 activation by the d715F G-CSFR, though notd715 G-CSFR mutation has been described previously
readily apparent from Figure 2A, was consistently ob-(McLemore et al., 1998). The d715 G-CSFR mutation
served at a level similar to wild-type after extended auto-introduces a premature stop codon that truncates the
radiography (data not shown). The failure of the d715Fcarboxy-terminal 96 amino acids of the G-CSFR and
G-CSFR to activate STAT-3 or STAT-5 was not second-reproduces the mutation found in a patient with severe
ary to a loss of myeloid cells or STAT protein expression,congenital neutropenia. The d715F G-CSFR allele was
since IL-6 and IL-3 induced a similar degree of STAT-3generated by introducing into the d715 allele an A!T
and STAT-5 activation in all samples.change at nucleotide 2362 via homologous recombina-
tion in embryonic stem (ES) cells (Figure 1B). Thus, the
d715F allele is predicted to produce a truncated G-CSFR The d715F Mice Have an Isolated Defect
in Granulopoiesisin which the sole remaining cytoplasmic tyrosine (Y704)
is mutated to phenylalanine. Mice carrying the d715F Homozygous d715F mice have normal white blood cell,
red blood cell, and platelet counts (Table 1). Moreover,allele were generated from a single targeted ES clone.
The fidelity of the d715F G-CSFR allele was confirmed the number and morphology of circulating lympho-
cytes, monocytes, and eosinophils are normal (data notby sequence analysis of PCR-amplified genomic DNA
isolated from mutant mice (data not shown). The d715F shown). However, homozygous d715F mice are neutro-
penic, with levels of circulating neutrophils z15% thatG-CSFR allele was inherited in a Mendelian fashion.
Homozygous d715F mice have normal growth, develop- of wild-type mice and similar to that observed in G-CSFR-
deficient mice (Liu et al., 1996). In the bone marrow, thement, and fertility and are grossly indistinguishable from
wild-type littermates. number and morphology of the erythroid, megakaryo-
cytic, and lymphoid lineages were within normal ranges.Cell surface expression of the d715F G-CSFR on he-
matopoietic cells from d715F mice was analyzed using In contrast to the severity of the neutropenia, only a
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Figure 1. Generation of Targeted Transgenic
Mice and Characterization of Mutant G-CSFR
Expression
(A) G-CSFR mutations. Schematic represen-
tations of the wild-type and mutant G-CSFRs.
The extracellular (ED), transmembrane (TM),
and cytoplasmic (CD) domains of the G-CSFR
are shown. The positions of cytoplasmic tyro-
sines (Y) and conserved box 1 and box 2 mo-
tifs are indicated.
(B) Targeting strategy. The genomic organi-
zation of the 39 region of the murine G-CSFR
gene is shown in the upper panel. Coding
exons are shown as black boxes and the 39
untranslated region as a hatched box. The
targeting vector is shown in the middle panel.
The asterisk indicates the C!G and A!T mu-
tations at nucleotides 2403 and 2362, respec-
tively. The recombined allele (Mt) is shown in
the lower panel. Note, the neomycin phos-
photransferase gene driven by the phospho-
glycerate kinase I promoter (neo) is present
in the 39 untranslated region.
(C) Flow cytometric analysis of biotinylated
G-CSF binding to peripheral blood leuko-
cytes. Peripheral blood leukocytes isolated
from wild-type, d715, and d715F mice were
incubated with biotinylated G-CSF in the ab-
sence (unshaded histogram) or presence
(shaded histogram) of a 100 M excess of non-
labeled G-CSF. Specific binding of biotinyl-
ated G-CSF is represented by the difference
between the two curves. Results shown are
gated on the neutrophil population.
modest reduction in neutrophils was observed in the marrow cells isolated from 715F mice after 7 days of
treatment with G-CSF (Figure 2C), suggesting thatbone marrow of d715F mice. Interestingly, a relative
accumulation of myeloid precursors was observed in STAT-3-independent mechanisms were responsible for
the neutrophil response in d715F mice.the bone marrow of d715F mice. In contrast, G-CSFR-
deficient mice demonstrate a uniform reduction in my-
eloid precursors, suggesting that G-CSF-induced gran-
ulocytic differentiation may be impaired in d715F mice G-CSF-Induced Cellular Proliferation Is Deficient
in d715F Progenitor Cells(Liu et al., 1996).
To assess the in vivo response to G-CSF, mice were To further characterize the ability of the d715F G-CSFR
to mediate G-CSF biological responses, the G-CSF-treated with G-CSF (10 mg/kg daily) for 7 days and the
neutrophil response in the blood assessed. As reported dependent proliferation and differentiation of hemato-
poietic progenitors isolated from these mice was exam-previously, d715 mice have an exaggerated increment
in circulating neutrophils in response to G-CSF (Figure ined. The number of IL-3-responsive progenitor cells in
the bone marrow of d715F mice was similar to that3) (McLemore et al., 1998). In contrast, the increment in
circulating neutrophils in d715F mice was markedly less observed with wild-type and d715 cells, indicating that
the production of myeloid progenitors was normal inthan that observed with d715 mice and actually less
than that observed with wild-type mice. Even after con- these mice (Figure 4). In contrast, G-CSF-induced colony
formation was markedly impaired. In fact, no G-CSF-sidering the 2- to 3-fold difference in the degree of leuko-
cytosis induced by G-CSF in C57BL/6 versus 129SvJ dependent colonies (based on standard criteria, defined
as containing at least 50 cells) were observed in culturesmice (Roberts et al., 1997), the difference between 715
and d715F mice appears significant (all mice in this study of d715F bone marrow cells (Metcalf, 1984). Instead of
the typical G-CSF-induced colony that averages ap-are outbred on a C57BL/6 3 129SvJ background). Inter-
estingly, in contrast to wild-type and d715 mice, no proximately 1000 cells per colony, d715F cells produced
only small clusters (15–20 cells) in response to G-CSF.evidence of STAT-3 activation was observed in bone
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cells were transduced with STAT-3C or vector alone
(MSCV) and their ability to form colonies in response to
G-CSF assessed. Transduction efficiency of hematopoi-
etic progenitor cells, based on EGFP expression in the
lineage-negative cell compartment, was 30%–40% for
STAT-3C and 50%–60% for MSCV (data not shown). In
wild-type or d715 cells, expression of STAT-3C did not
result in cytokine-independent colony formation nor did
it consistently effect IL-3 or G-CSF responsiveness (Fig-
ure 5). Likewise, in d715F cells, expression of STAT-3C
did not result in cytokine-independent colony formation
nor significantly effect IL-3-dependent colony forma-
tion. However, expression of STAT-3C did partially re-
store their ability to form colonies in response to G-CSF.
In fact, after accounting for transduction efficiency
(30%–40% for STAT-3C), it appears that the G-CSF re-
sponsiveness of STAT-3C expressing d715F progenitor
cells is similar to that of wild-type progenitor cells. Con-
sistent with this observation, the G-CSF-dependent col-
onies produced by STAT-3C-transduced d715F progen-
itor cells were of nearly normal size; the number of cells
per colony (mean of three independent experiments) for
d715F cells transduced with MSCV or STAT-3C was
,100 and 462, respectively (compared with 1126 and
827 cells per colony for wild-type cells transduced with
MSCV or STAT-3C, respectively). Collectively, these
data show that the expression of STAT-3C in d715F
progenitor cells partially rescues G-CSF-induced cellu-
lar proliferation.
Activation of STAT-3 May Contribute to G-CSF-
Induced Granulocytic Differentiation
As noted above, there is an accumulation of myeloid
precursors in the bone marrow of d715F mice, sug-
gesting that granulocytic differentiation may be im-
Figure 2. Activation of STAT Proteins by the d715F G-CSFR
paired. However, the neutrophils present in the blood
(A and B) Bone marrow cells isolated from wild-type (Wt) and homo-
of d715F mice following G-CSF treatment are morpho-zygous d715 and d715F G-CSFR mutant mice were stimulated with
logically normal and express normal levels of MMP-9G-CSF (100 ng/ml), IL-6 (20 ng/ml), IL-3 (10 ng/ml), or no cytokine
(gelatinase B), a protease expressed at the metamyelo-for 10 min. Nuclear extracts were incubated with radiolabeled m67
probe (A and C) or b-cas probe (B) and complexes resolved on a cyte/band stage of differentiation and widely considered
nondenaturing polyacrylamide gel. The identity of specific com- a marker of terminal granulocytic differentiation (data
plexes was confirmed by supershifting with specific antibodies (data not shown) (Borregaard and Cowland, 1997). Since
not shown).
many cytokines contribute to granulopoiesis in vivo, we(C) The indicated mice were treated with G-CSF (10 mg/kg/day) for
examined G-CSF-dependent granulocytic differentia-7 days. Bone marrow cells were isolated 4 hr after the last injection
tion of d715F progenitor cells. Morphologic analysis ofand analyzed for STAT-3 activation, as described above.
cells contained in colonies generated after 7 days in
G-CSF-stimulated methylcellulose cultures revealed that,
while wild-type or d715 colonies contained 40%–50%Expression of a Constitutively Active Form
of STAT-3 in d715F Bone Marrow Cells Restores mature neutrophils, d715F “colonies” contained less
than 5% neutrophils (data not shown).G-CSF-Induced Cellular Proliferation
To determine if the loss of G-CSF-induced cellular prolif- To further examine the contribution of STAT-3 to G-CSF-
dependent granulocytic differentiation, a system waseration in d715F progenitor cells was due to loss of
STAT-3 activation, a constitutively active form of STAT-3 developed to examine in detail the differentiation of
d715F progenitor cells transduced with STAT-3C orwas introduced into bone marrow cells via retroviral
transduction. This mutant STAT-3 protein (termed STAT- MSCV alone. Retrovirally transduced (EGFP1), lineage-
negative bone marrow cells were sorted by flow cytome-3C) contains two cysteine substitutions in its SH2 domain,
which results in spontaneous dimerization (Bromberg et try and cultured for 7 days in the presence of G-CSF
(100 ng/ml) and stem cell factor (SCF) (100 ng/ml); theal., 1999). STAT-3C was introduced into a murine stem
cell virus (MSCV) retroviral vector containing an internal lineage-negative cell population is enriched for progeni-
tors and, importantly, contains no myeloid precursorsribosomal entry sequence (IRES) motif linked to the en-
hanced green fluorescent protein (EGFP) to track trans- or mature myeloid cells. Stem cell factor was added to
the culture to support the growth of early progenitors,duced cells. Wild-type, d715, or d715F bone marrow
STAT-3 Activation by G-CSF
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Table 1. Blood and Bone Marrow Analysis
Wild-Type d715 d715F
Blood
Number of mice analyzed 15 10 9
WBC (3 1029/L) 9.74 6 1.06 10.00 6 1.04 9.56 6 2.60
RBC (3 10212/L) 8.92 6 0.26 9.01 6 0.19 10.20 6 0.56
Platelets (3 1029/L) 1,025 6 66 980 6 72 1,098 6 194
Neutrophils (%) 10.9 6 4.6 8.8 6 2.6 2.0 6 1.2*
Neutrophils (3 1029/L) 1.07 6 0.27 0.88 6 0.24 0.16 6 0.04*
Bone Marrow
Total nucleated cells (3 1026) (per femur) 28.1 6 6.0 32.9 6 5.8 29.3 6 6.0
Band and segmented neutrophil (%) 28.2 6 5.0 33.7 6 2.8 19.3 6 8.9*
Metamyelocyte neutrophil (%) 13.6 6 0.9 14.5 6 0.9 8.8 6 1.6*
Myelocyte neutrophil (%) 6.6 6 1.1 7.6 6 1.0 12.8 6 4.4*
Promyelocytes (%) 2.4 6 0.4 2.5 6 0.4 3.5 6 1.9
Myeloblasts (%) 0.1 6 0.0 0.1 6 0.1 0.2 6 0.0
Eosinophil lineage (%) 2.4 6 0.4 3.3 6 0.6 3.1 6 0.6
Lymphoid lineage (%) 18.1 6 3.9 13.6 6 0.9 23.8 6 3.8
Erythroid lineage (%) 28.5 6 2.8 25.1 6 1.2 26.8 6 6.7
Myeloid/erythroid ratio 2.9 6 0.3 3.5 6 0.4 2.2 6 0.9
Manual 300-count leukocyte differentials were performed on blood smears from 5- to 6-week-old mice. Bone marrow analysis was based on
500-count manual leukocyte differentials performed on nucleated cells recovered from the femurs of six to eight age-matched mice of each
genotype. Data represent the mean 6 SD. p , 0.05 compared to wild-type and d715.
since preliminary studies showed minimal cell growth were mature neutrophils (Figure 6). In contrast, in cul-
tures of MSCV-transduced d715F cells, the majority ofwith G-CSF or stem cell factor alone (data not shown).
These culture conditions support a robust and nearly cells were myeloid precursors with only 5% mature neu-
trophils. Expression of STAT-3C in d715F progenitorssynchronized wave of granulopoiesis that allows for the
detailed study of G-CSF-dependent granulocytic differ- led to an increase in both total cell number and percent-
age of mature neutrophils. Importantly, no significantentiation. In cultures of MSCV- or STAT-3C-transduced
wild-type cells, z50% of the cells present after 7 days growth of STAT-3C-transduced bone marrow cells was
observed in cultures stimulated with SCF alone. Collec-
Figure 4. Hematopoietic Progenitor Assays
Bone marrow mononuclear cells were plated in methylcellulose-
Figure 3. In Vivo Response to G-CSF containing media supplemented with 100 ng/ml of G-CSF or 10 ng/
ml of IL-3. Hematopoietic colonies containing 50 or more cells wereFive age- and sex-matched mice of each genotype were treated
with human G-CSF (10 mg/kg/day) for 7 days. The absolute neutro- scored on day 7. The data were normalized to the number of colonies
present in cultures of wild-type cells. Data represent the mean 6 SD.phil count in the blood was determined before and 4 hr after the
last injection of G-CSF. Data represent the mean 6 SD. *P , 0.05 1P , 0.05 versus wild-type and d715F; *only small clusters containing
15–20 cells were observed. Data represent the mean 6 SD.versus G-CSF-treated d715 mice.
Immunity
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Figure 5. Expression of STAT-3C in d715F Hematopoietic Progenitor Cells Restores Their G-CSF Responsiveness
Bone marrow cells from the indicated genotype were retrovirally transduced with MSCV or STAT-3C and their growth in response to no
cytokine, G-CSF (10 ng/ml), or IL-3 (10 ng/ml) measured in standard methylcellulose cultures. 2000 (IL-3) or 5000 (no cytokine and G-CSF)
cells per dish were plated and the total number of colonies scored on day 7. Transduction efficiency of hematopoietic progenitors, as estimated
by EGFP expression in lineage-negative cells, was 30%–40% for STAT-3C and 50%–60% for MSCV (data not shown). *No colonies were
observed in the absence of cytokine. The data are representative of three independent experiments.
tively, these data suggest that STAT-3 activation con- STAT-5 activation by G-CSF in these cells were assayed
tributes to G-CSF-dependent granulocytic differenti- using gel shift assays to monitor DNA binding activity
ation. (Figures 7B and 7C). In cells transduced with STAT-3D,
G-CSF-dependent activation of STAT-3 was significantly
attenuated, although residual activation was detectedExpression of a Dominant-Negative Form of STAT-3
after stimulation with 10 ng/ml of G-CSF. G-CSF-inducedin Wild-Type Bone Marrow Cells Impairs Their
activation of STAT-5 was modest but comparable inG-CSF-Dependent Proliferation and Differentiation
wild-type cells transduced with MSCV or STAT-3D. Fur-To further examine the contribution of STAT-3 to G-CSF-
thermore, no consistent effect of STAT-3D expressiondependent granulocytic differentiation and proliferation,
was observed in IL-3-induced activation of STAT-5, sug-a well-characterized dominant-negative form of STAT-3
gesting that STAT-3D had no significant effect on STAT-5(STAT-3D) was introduced into wild-type bone marrow
activation.cells via retroviral transduction, as described above (Na-
We next examined the effect of STAT-3D expressionkajima et al., 1996). To characterize STAT-3D expres-
on IL-3 and G-CSF-induced colony formation (Figuresion, EGFP-positive lineage-negative cells were sorted
7A). Expression of STAT-3D led to a modest, but nonsig-by flow cytometry and expanded for 5 to 6 days in media
supplemented with IL-3 and SCF ligand. STAT-3 and nificant, reduction in the number of IL-3-dependent col-
Figure 6. G-CSF-Induced Granulocytic Differentiation
Bone marrow cells were transduced with MSCV or STAT-3C. Transduced (EGFP-positive) lineage-negative cells were sorted by flow cytometry
and cultured in the presence of G-CSF (100 ng/ml) and stem cell factor (100 ng/ml) for 7 days. (A) 200-count manual leukocyte differentials
of cells present on day 7 of culture. (B) Photomicrograph of Wright-Giemsa stained cells. Original magnification: 1003 (upper panel) and 2503
(lower panel). Arrows indicate mature neutrophils. The data are representative of three independent experiments.
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Figure 7. Expression of STAT-3D in Wild-
Type Hematopoietic Progenitor Cells Inhibits
G-CSF-Dependent Colony Formation
(A) Bone marrow cells were retrovirally trans-
duced with MSCV or STAT-3D, and their
growth in response to IL-3 and G-CSF was
measured in standard methylcellulose cultures.
Transduction efficiency of hematopoietic pro-
genitors, as estimated by EGFP expression in
lineage-negative cells, was 60%–80% for
STAT-3D and 80%–90% for MSCV (data not
shown). Due to significant interexperimental
variability, the colony data for each experi-
ment were normalized to the number of colo-
nies observed in cultures of MSCV-trans-
duced cells stimulated with IL-3. Data
represent the mean 6 SD of five independent
experiments. *P , 0.05 versus MSCV.
(B and C) Transduced (EGFP-positive) lin-
eage-negative cells were sorted by flow cy-
tometry, cultured in the presence of kit ligand
(100 ng/ml) and IL-3 (20 ng/ml) for 5 to 6 days,
and then analyzed for STAT-3 and STAT-5
activation. In (B), the cells were stimulated
with no cytokine (0) or G-CSF (at the indicated
concentration in ng/ml) for 10 min; in (C), the
cells were stimulated with no cytokine, G-CSF,
or IL-3 (10 ng/ml) for 10 min. Equal amounts of
nuclear extracts (except for IL-3-stimulated
cells in which 5-fold less extract was used)
were incubated with radiolabeled m67 probe
(B) or b-cas probe (C) and complexes resolved
on a nondenaturing polyacrylamide gel.
onies. In contrast, STAT-3D expression resulted in a performed predominantly with immortalized cell lines.
These studies suggest at least two mechanisms ofdose-dependent reduction in both the number and size
STAT-3 activation by the G-CSFR (Ward et al., 1999). Atof colonies formed in response to G-CSF (Figure 7A; data
low concentrations of G-CSF (1 ng/ml), STAT-3 activa-not shown). Cytological examination of G-CSF-dependent
tion is dependent upon receptor tyrosines, presumablycolonies revealed a partial block in differentiation in the
through a direct docking mechanism with Y704 andSTAT-3D-transduced colonies; in one representative ex-
Y744 of the G-CSFR. In contrast, at saturating concen-periment, MSCV-transduced colonies contained 64% neu-
trations of G-CSF (.10 ng/ml), STAT-3 activation alsotrophils and bands, 34% metamyelocytes and myelocytes,
occurs in a tyrosine-independent fashion (Chakraborty0% promyelocytes and blasts, and 2% macrophages,
et al., 1999; Ward et al., 1999). In the present study, wewhile STAT-3D-transduced colonies contained 5% neu-
show that mutation of Y704 in the context of the d715trophils and bands, 76% metamyelocytes and myelo-
G-CSFR truncation mutant abrogates G-CSF-depen-cytes, 17% promyelocytes and blasts, and 2% macro-
dent STAT-3 activation in primary myeloid cells even atphages. Collectively, these data show that expression
saturating (100 ng/ml) concentrations of G-CSF. Thus,of dominant-negative STAT-3 in murine progenitors in-
these data provide additional evidence that Y704 of thehibits their G-CSF-dependent proliferation and differen-
G-CSFR is an important mediator of STAT-3 activationtiation.
in vivo.
Recent studies have suggested that the membrane-
Discussion proximal region of the G-CSFR, containing the con-
served box 1 and box 2 motifs but lacking tyrosines, is
The G-CSFR activates STAT-3, STAT-5, and to a lesser sufficient to activate STAT-5 and STAT-1 (de Koning et
degree STAT-1 (Avalos, 1996; Avalos et al., 1997). Previ- al., 1996; Avalos et al., 1997; Dong et al., 1998; Ward et
ous studies of the signal transduction pathways utilized al., 1999). Consistent with these studies, STAT-1 activa-
tion by the d715F G-CSFR is normal, confirming that itsby the G-CSFR to activate STAT proteins have been
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activation predominantly occurs in a receptor tyrosine- was detected in bone marrow cells isolated from d715F
mice after in vivo treatment with G-CSF (Figure 2C).independent fashion. In contrast, we show that STAT-5
activation by the d715F G-CSFR in primary myeloid cells To assess the contribution of STAT-3 to the defect
in G-CSF-induced cellular proliferation, a constitutivelyis markedly attenuated, suggesting that in vivo, Y704 of
the G-CSFR is an important mediator of STAT-5 acti- active form of STAT-3 (STAT-3C) was expressed in
d715F myeloid cells. Expression of STAT-3C restoredvation.
STAT proteins have been implicated in the regulation nearly normal G-CSF responsiveness of d715F progeni-
tor cells, suggesting that the defect in G-CSF-inducedof cellular proliferation and survival. In fact, constitutive
activation of STAT-5 and STAT-3 has been observed cellular proliferation was due to a loss of STAT-3 activa-
tion. Alternatively, it is possible that the observed rescuein certain human malignancies, suggesting that their
inappropriate activation may contribute to neoplastic of G-CSF responsiveness by STAT-3C may represent
activation of nonphysiological signaling pathways. Thistransformation (Gouilleux-Gruart et al., 1997; Bowman
et al., 2000; Song et al., 2000; Ward et al., 2000). With possibility, although not excluded, is unlikely for the
following reasons. First, although STAT-3C has beenrespect to the G-CSFR, both STAT-3 and STAT-5 have
been implicated in the transduction of proliferative sig- demonstrated to transform fibroblast cell lines, expres-
sion of STAT-3C in primary myeloid cells did not resultnals. In mice lacking STAT5a and STAT5b, even though
circulating numbers of neutrophils were normal, the in cytokine-independent growth (Bromberg et al., 1999).
Second, STAT-3C expression in wild-type or d715 bonenumber of colonies produced in response to G-CSF
was reduced 2-fold (Teglund et al., 1998). Although the marrow cells had no effect on their growth or differen-
tiation in response to G-CSF or IL-3. Finally, expres-targeted disruption of the STAT-3 gene leads to embry-
onic lethality, mice with a conditional knockout of STAT-3 sion of a dominant-negative form of STAT-3 in wild-type
progenitor cells resulted in impaired G-CSF respon-resulting in its myeloid-specific deletion are viable
(Takeda et al., 1997, 1999). In these mice, granulopoiesis siveness, providing independent evidence that STAT-3
activation is required for the transduction of normal pro-appeared normal, as evidenced by normal neutrophil
numbers and morphology in the blood. In this elegant liferative signals by the G-CSFR.
In contrast to this conclusion, two previous studiesstudy, the STAT-3 gene was conditionally deleted using
the Cre-lox recombination system in which the Cre- showed that expression of dominant-negative forms of
STAT-3 (including STAT-3D) in myeloid cell lines re-recombinase was expressed under the control of the
murine lysozyme M gene regulatory region. Since lyso- sulted in enhanced G-CSF-dependent proliferation and
a block in granulocytic differentiation (Shimozaki et al.,zyme M is expressed at the promyeloctye stage of gran-
ulocytic differentiation (Faust et al., 2000), and since 1997; de Koning et al., 2000). Although a definitive expla-
nation for the apparent discrepancy in these results isthere is a delay between gene excision and the loss of
gene product, it is likely that STAT-3 function was lost not known, it is possible that the mechanisms regulating
cellular proliferation and differentiation may differ signif-very late during granulocytic differentiation. Thus, it is
difficult to draw any conclusions about the role of STAT-3 icantly between these cell lines and primary myeloid
cells.in granulopoiesis from this transgenic mouse model.
However, it should be noted that this study did show The residual neutrophils present in d715F mice are
phenotypically normal, as evidenced by their normalthat the suppressive effects of IL-10 on mutant neutro-
phils were completely abolished, demonstrating that morphology and expression of MMP-9 (data not shown).
However, there is a significant accumulation of myeloidSTAT-3 is required for normal neutrophil function.
In the present study, we show that mice homozygous precursors in the bone marrow of these mice. Together,
these observations suggested a delay, but not absolutefor the d715F G-CSFR have impaired basal granulo-
poiesis. They are neutropenic with levels of circulating block, in granulocytic differentiation in d715F mice.
Since multiple cytokines contribute to granulopoiesisneutrophils similar to that observed in G-CSFR-deficient
mouse (Liu et al., 1996). Moreover, G-CSF-induced col- in vivo, we developed a system to study the G-CSF-
dependent granulocytic differentiation of murine hema-ony formation in vitro is markedly impaired. Together,
these data suggest that the transduction of cellular pro- topoietic progenitor cells in vitro. In cultures of d715F
progenitor cells, a relative accumulation of myeloid pre-liferative signals by the d715F G-CSFR is impaired. In
contrast to the markedly impaired G-CSF-induced cellu- cursors and loss of mature neutrophils, indicative of a
partial block in granulocytic differentiation, was ob-lar proliferation observed in vitro, the in vivo neutrophil
response to G-CSF in d715F mice was not significantly served. Moreover, expression of STAT-3C in d715F pro-
genitor cells partially rescued their G-CSF-dependentdifferent from that observed in wild-type mice, although
it was dramatically less than that seen in the d715 mice. granulocytic differentiation. These results are consistent
with at least two possibilities. The transduction of differ-This apparent discrepancy between in vitro and in vivo
G-CSF responsiveness suggests that G-CSFR-indepen- entiation signals by the d715F G-CSFR may be impaired.
Alternatively, the transduction of survival signals by thedent signals may be contributing to the stimulation of
granulopoiesis in G-CSF-treated d715F mice. Interleu- d715F G-CSFR may be impaired, leading to a selective
loss of mature neutrophils. The latter results seem lesskin-6 and granulocyte-macrophage colony stimulating
factor are potential candidates to provide these signals, likely for several reasons. First, no increase in the num-
ber of morphologically apoptotic neutrophils was ob-since both cytokines have been shown to contribute to
granulopoieisis in mice lacking the G-CSFR or G-CSF, served in cultures of d715F cells. Second, the normal
blood neutrophil count in mice lacking STAT-3 in theirrespectively (Liu et al., 1997; Seymour et al., 1997). Inter-
estingly, these putative signals appear to be STAT-3 neutrophils suggests that STAT-3 expression is not re-
quired to maintain normal neutrophil survival in vivoindependent, since no evidence of STAT-3 activation
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of the ES clones yielded germline transmission of the d715F allele.(Takeda et al., 1999). Collectively, these data suggest
All mice were housed in a specific-pathogen free environment andthat, although not required, STAT-3 activation by G-CSF
examined daily by veterinary staff for signs of illness.may contribute significantly to the regulation of granulo-
cytic differentiation.
Flow Cytometry
As outlined in the introduction, the contribution of G-CSF Binding
G-CSFR signals to the regulation of granulocytic differ- To assess surface G-CSFR expression, peripheral blood mononu-
clear cells were incubated at 48C for 1 hr with biotinylated G-CSFentiation is controversial. The presence of morphologi-
(generated as described [Liu et al., 1996], 5 ng per 106 cells) in thecally mature neutrophils in G-CSFR-deficient mice dem-
presence or absence of a 100-fold molar excess of nonlabeled G-CSF,onstrates that G-CSFR signals are not required for
followed by incubation with PE-conjugated streptavidin (Gibco BRL,granulocytic differentiation. Indeed, the accumulation of
Rockville MD). The neutrophil population was gated based on for-
myeloid precursors in the bone marrow of d715F mice ward- and side-scatter characteristics.
is not present in G-CSFR-deficient mice (Liu et al., 1996). Transduction Efficiency
Nonadherent cells were harvested from the retroviral-producingThese observations suggest that it is not simply the
monolayer by gentle tituration and incubated with a cocktail of phy-loss of differentiative signals but rather an imbalance
coerythrin (PE)-conjugated rat anti-mouse lineage markers, includ-between proliferative and differentiative signals by the
ing Gr-1 (myeloid cells), B220 (B lymphocytes), and CD3 (T lympho-d715F G-CSFR that leads to the partial block in granulo-
cytes). After incubation at 48C for 30 min cells were washed; they
cytic differentiation in d715F mice. were then analyzed using a FACScan flow cytometer and CellQuest
It is likely that the d715F G-CSFR mutation may alter version 1.2.2 software (Becton-Dickinson, Mansfield MA). Transduc-
tion efficiency was defined as the percentage of lineage-negativeother signaling pathways besides STAT-3 that contrib-
cells that expressed EGFP. All antibodies were purchased fromute to G-CSF-dependent proliferation and differentia-
PharMingen (San Diego, CA).tion. Indeed, STAT-5 activation by the d715F G-CSFR
Cell Sortingis both diminished and delayed. Although the findings
Nonadherent cells harvested from the retroviral-producing mono-
in the present study suggest that STAT-3 is the principal layer were incubated with the same cocktail of lineage markers, and
STAT protein mediating G-CSF-induced proliferation lineage-negative EGFP-positive cells were sorted using a Coulter
Elite ESP cytometer (Coulter, Hialeah, FL).and differentiation, these data do not exclude a minor
role for STAT-5. It is possible that the failure of STAT-
G-CSF Binding Experiments3C expression to completely restore normal G-CSF re-
Binding experiments were performed as previously described withsponsiveness in d715F progenitors is due to impaired
minor modifications (Semerad et al., 1999). In brief, 5.0 3 106 boneSTAT-5 activation.
marrow cells were incubated in triplicate with eight different concen-
In summary, to examine the contribution of STAT pro- trations of 125I-[Tyr1, Tyr3]rhG-CSF for 3 hr at 158C in the presence
teins to the transduction of biological signals by the or absence of at least a 50-fold excess of unlabeled rhG-CSF. Cell
bound versus free 125I-[Tyr1, Tyr3] rhG-CSF was measured using aG-CSFR, we generated transgenic mice containing a
LKB-Wallac CliniGamma 1272–004 g counter (Wallac Oy, Finland).targeted mutation of their G-CSFR in which G-CSF-
Dissociation constants (Kd) were calculated from two independentdependent activation of STAT-3 is absent and STAT-5
experiments. 125I-[Tyr1, Tyr3] rhG-CSF was kindly provided by Phar-activation markedly impaired. We provide evidence that
macia (Peapack, NJ)
STAT-3 activation is critical for the transduction of prolif-
erative signals by the G-CSFR and may also contribute Electrophoretic Mobility Shift Assay
to the regulation of granulocytic differentiation. The Bone marrow cells (1 3 107) were resuspended in Opti-MEM 1 (Gibco
BRL, Grand Island, NY) media with 1% fetal calf serum and stimu-STAT-3-responsive targets that mediate these biologi-
lated at 378C with buffer alone or with the indicated cytokines forcal responses are currently under investigation.
the indicated period of time. Nuclear extracts were prepared as
previously described (Hermans et al., 1999). One microgram of nu-Experimental Procedures
clear extract was incubated for 20 min at room temperature with
25,000 CPM of P32-labeled double-stranded oligonucleotide probeGeneration of d715F Mice
and 1 mg of poly (dI:dC) in 20 ml of binding buffer (10 mM Tris [pHThe d715 G-CSFR mutant mice were generated in our laboratory,
7.5], 100 mM KCL, 5 nM MgCL, 10% Glycerol, and 1 mM DTT).as previously described (McLemore et al., 1998). To generate the
Complexes were resolved on a 5% nondenaturing polyacrylamided715F targeting vector, an A!T substitution at nucleotide 2362 of
gel. The gel was subsequently dried and analyzed by autoradiogra-the murine G-CSFR gene was introduced by site-directed muta-
phy. The following double-stranded oligonucleotides were used:genesis into the d715 targeting vector using the following primers:
m67 (59-CATTTCCCGTAAATCAT-39), a high-affinity mutant of theforward, 59-GGTTCAGGCCTTTGTGCTCCAAGGAGATC-39; and re-
sis-inducible element of the human c-fos gene; and b-caseinverse, 59-TGGAGCACAAAGGCCTGAACCAGGGCT-39. Thus, the d715F
(59-GATTTCTAGGAATTCAATCC-39), the STAT-5 binding site of thetargeting vector is designed to introduce two separate mutations
bovine b-casein promoter. For supershift analysis, nuclear extractsinto the wild-type G-CSFR gene: a C!G mutation at nucleotide
were preincubated for 1 hr at 48C with specific antibodies to STAT-32403 (also present in the d715 allele) that introduces a premature
(#ST3-5G7, ZYMED, San Francisco, CA) or STAT-5 (#sc-835, Santastop codon leading to the truncation of the distal 96 amino acids
Cruz Biotechnology, Santa Cruz, CA) prior to the addition of radiola-of the G-CSFR; and the A!T substitution at nucleotide 2362 (present
beled oligonucleotide. For STAT-3D- and MSCV-transduced cells,only in the d715F allele) that mutates the sole remaining cytoplasmic
lineage-negative EGFP-positive cells were sorted by flow cytometrytyrosine (Y704) to phenylalanine.
and expanded in Myelocult 5300 (Stem Cell Technologies) supple-RW4 embryonic stem (ES) cells (a gift from T.J. Ley, Washington
mented with IL-3 (10 ng/ml) and SCF (100 ng/ml). After 5 to 6 daysUniversity, St. Louis, MO) were transfected with the Nsi-1-linearized
in culture, cells were washed extensively and then incubated for 4d715F targeting vector, and G418-resistant clones were isolated
hr in Opti-MEM with 1% FCS prior to cytokine stimulation.essentially as described (Hug et al., 1996). Two independent clones
that had undergone homologous recombination were identified by
Southern analysis, as described previously (McLemore et al., 1998). Peripheral Blood and Bone Marrow Analysis
Blood was obtained by retro-orbital venous plexus sampling in poly-C57BL/6 blastocysts were microinjected with ES cells from each of
these clones and implanted into pseudopregnant Swiss Webster propylene tubes containing EDTA. Complete blood counts were
determined using a Hemavet automated cell counter (CDC Technol-foster females, as described previously (Hug et al., 1996). Only one
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ogies, Inc., Oxford, CT). Bone marrow was harvested by flushing In Vitro Suspension Culture System
10,000 EGFP-positive lineage-negative cells were suspended in My-both femoral bones with a-minimum essential medium (a-MEM)
containing 10% fetal bovine serum. Manual leukocyte differentials elocult 5300 containing 100 ng/ml SCF and 100 ng/ ml of G-CSF
and incubated for 7 days at 378C in a 5% CO2 humidified chamber.were performed on Wright-stained blood smears or cytospin prepa-
rations of bone marrow mononuclear cells.
Statistical Analysis
Data are presented as mean 6 standard deviation (SD). Statistical
Hematopoietic Progenitor Cell Assays significance was assessed by Student’s t test.
A total of 5–10 3 104 bone marrow mononuclear cells were plated
in 2.5 ml of methylcellulose media (MethoCult 3230; Stem Cell Tech-
Acknowledgmentsnologies, Vancouver, BC, Canada) supplemented with human G-CSF
(100 ng/ml, Amgen, Thousand Oaks, CA) or with murine IL-3 (10 ng/
The authors thank Tim Graubert, Jessica Pollock, Tim Ley, andml, R&D Systems, Minneapolis, MN) and placed in a humidified
Christine Pham for their thoughtful discussions and advice. Thischamber with 5% CO2. Colonies containing at least 50 cells were work was supported by the Edward Mallinckrodt, Jr., Foundationscored on day 7 of culture. For retrovirally transduced bone marrow
(DCL), by a grant from the National Institutes of Health NHLBI (R01cells, a total of 4–10 3 103 mononuclear cells were plated in 2.5 ml
HL60772-01A1 [D. C. L.]), and by a training grant from the Nationalof methylcellulose media.
Institutes of Health NHLBI (T32 HL 07088-23 [M. L. M.]).
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